Product Showcase
Explore our comprehensive portfolio of pharmaceutical products
APIs
Bupropion Hydrochloride
Therapy
: Central nervous system and pain
Target
: DAT;Adrenoceptors
CAS
: 31677-93-7
MF
: C13H18ClNO•HCl
MW
: 276.2
Levetiracetam
Therapy
: Central nervous system and pain
Target
: SV2A
CAS
: 102767-28-2
MF
: C8H14N2O2
MW
: 170.21
Quetiapine Fumarate
Therapy
: Central nervous system and pain
Target
: 5-HT2A;DRD2
CAS
: 111974-72-2
MF
: C21H25N3O2S•1/2(C4H4O4)
MW
: 441.55
Fluoxetine Hydrochloride
Therapy
: Central nervous system and pain
Target
: Serotonin Transporter;Autophagy
CAS
: 56296-78-7
MF
: C17H19ClF3NO
MW
: 345.79
Memantine HCl
Therapy
: Central nervous system and pain
Target
: NMDAR
CAS
: 41100-52-1
MF
: C12H21N•HCl
MW
: 215.76
Venlafaxine Hydrochloride
Therapy
: Central nervous system and pain
Target
: SERT;NET
CAS
: 99300-78-4
MF
: C17H27NO2•HCl
MW
: 313.86
Desvenlafaxine Succinate
Therapy
: Central nervous system and pain
Target
: SERT;NET
CAS
: 386750-22-7
MF
: C20H31NO6
MW
: 381.47
Pregabalin
Therapy
: Central nervous system and pain
Target
: CACNA2D1
CAS
: 148553-50-8
MF
: C8H17NO2
MW
: 159.23
Gabapentin
Therapy
: Central nervous system and pain
Target
: CACNA1B;CACNA2D2
CAS
: 60142-96-3
MF
: C9H17NO2
MW
: 171.24
Brivaracetam
Therapy
: Central nervous system and pain
Target
: SV2A
CAS
: 357336-20-0
MF
: C11H20N2O2
MW
: 212.29
Lacosamide
Therapy
: Central nervous system and pain
Target
: NMDAR;SCNA
CAS
: 175481-36-4
MF
: C13H18N2O3
MW
: 250.29
Aripiprazole
Therapy
: Central nervous system and pain
Target
: 5-HT1A;DRD3;5-HT7;DRD4;5-HT2C;5-HT2A;ADRA1A;DRD2;HRH1
CAS
: 129722-12-9
MF
: C23H27Cl2N3O2
MW
: 448.39
Escitalopram Oxalate
Therapy
: Central nervous system and pain
Target
: SERT
CAS
: 219861-08-2
MF
: C22H23FN2O5
MW
: 414.43
Lamotrigine
Therapy
: Central nervous system and pain
Target
: SCNA
CAS
: 84057-84-1
MF
: C9H7Cl2N5
MW
: 256.09
Levodopa
Therapy
: Central nervous system and pain
Target
: DRDs
CAS
: 59-92-7
MF
: C9H11NO4
MW
: 197.19
Lurasidone
Therapy
: Central nervous system and pain
Target
: 5-HT7;5-HT1A;5-HT2A;DRD2
CAS
: 367514-87-2
MF
: C28H36N4O2S
MW
: 492.68
Paroxetine Hydrochloride, Anhydrous
Therapy
: Central nervous system and pain
Target
: SERT
CAS
: 78246-49-8
MF
: C19H21ClFNO3
MW
: 365.83
Paroxetine Hydrochloride, Hemihydrate
Therapy
: Central nervous system and pain
Target
: G Protein-coupled Receptor Kinase (GRK)
CAS
: 110429-35-1
MF
: C19H23ClFNO4
MW
: 383.84
Risperidone
Therapy
: Central nervous system and pain
Target
: 5-HT2A;DRD2
CAS
: 106266-06-2
MF
: C23H27FN4O2
MW
: 410.48
Rocuronium Bromide
Therapy
: Central nervous system and pain
Target
: AChR
CAS
: 119302-91-9
MF
: C32H53BrN2O4
MW
: 609.68
Ropinirole Hydrochloride
Therapy
: Central nervous system and pain
Target
: DRD2
CAS
: 91374-20-8
MF
: C16H25ClN2O
MW
: 296.84
Safinamide
Therapy
: Central nervous system and pain
Target
: MAOB
CAS
: 133865-89-1
MF
: C17H19FN2O2
MW
: 302.34
Carbidopa
Therapy
: Central nervous system and pain
Target
: DDC
CAS
: 38821-49-7
MF
: C10H16N2O5
MW
: 244.25
Amisulpride
Therapy
: Central nervous system and pain
Target
: DRD3;DRD2
CAS
: 71675-85-9
MF
: C17H27N3O4S
MW
: 369.48
Citalopram
Therapy
: Central nervous system and pain
Target
: SERT
CAS
: 59729-33-8
MF
: C20H21FN2O
MW
: 324.39
Donepezil Hydrochloride
Therapy
: Central nervous system and pain
Target
: AChE
CAS
: 120011-70-3
MF
: C24H30ClNO3
MW
: 415.95
Duloxetine Hydrochloride
Therapy
: Central nervous system and pain
Target
: SERT;NET
CAS
: 136434-34-9
MF
: C18H20ClNOS
MW
: 333.88
Acamprosate Calcium
Therapy
: Central nervous system and pain
Target
: NMDAR
CAS
: 77337-73-6
MF
: C10H20CaN2O8S2
MW
: 400.48
Carbamazepine
Therapy
: Central nervous system and pain
Target
: SCNA
CAS
: 298-46-4
MF
: C15H12N2O
MW
: 236.27
Citalopram Hydrobromide
Therapy
: Central nervous system and pain
Target
: SERT
CAS
: 59729-32-7
MF
: C20H22BrFN2O
MW
: 405.3
Clomipramine Hydrochloride
Therapy
: Central nervous system and pain
Target
: SERT;NET
CAS
: 17321-77-6
MF
: C19H24Cl2N2
MW
: 351.31
Divalproex Sodium
Therapy
: Central nervous system and pain
Target
: GABAT
CAS
: 76584-70-8
MF
: C8H17NaO2
MW
: 168.21
Fluvoxamine Maleate
Therapy
: Central nervous system and pain
Target
: SERT
CAS
: 61718-82-9
MF
: C19H25F3N2O6
MW
: 434.41
Magnesium Valproate
Therapy
: Central nervous system and pain
Target
: GABAT;GSK3
CAS
: 62959-43-7
MF
: C16H30MgO4
MW
: 310.71
Metamizole
Therapy
: Central nervous system and pain
Target
:
CAS
: 68-89-3
MF
: C13H16N3NaO4S
MW
: 333.34
Mirtazapine
Therapy
: Central nervous system and pain
Target
:
CAS
: 85650-52-8
MF
: C17H19N3
MW
: 265.35
Naltrexone Hydrochloride
Therapy
: Central nervous system and pain
Target
:
CAS
: 16676-29-2
MF
: C20H24ClNO4
MW
: 377.87
Olanzapine
Therapy
: Central nervous system and pain
Target
: 5-HT2;DRD1;DRD2
CAS
: 132539-06-1
MF
: C17H20N4S
MW
: 312.43
Oxcarbazepine
Therapy
: Central nervous system and pain
Target
:
CAS
: 28721-07-5
MF
: C15H12N2O2
MW
: 252.27
Riluzole
Therapy
: Central nervous system and pain
Target
: SCNA
CAS
: 1744-22-5
MF
: C8H5F3N2OS
MW
: 234.2
Rivastigmine Tartrate
Therapy
: Central nervous system and pain
Target
:
CAS
: 129101-54-8
MF
: C18H28N2O8
MW
: 400.42
Ropinirole
Therapy
: Central nervous system and pain
Target
:
CAS
: 91374-21-9
MF
: C16H24N2O
MW
: 260.37
Sertraline Hydrochloride
Therapy
: Central nervous system and pain
Target
:
CAS
: 79559-97-0
MF
: C17H18Cl3N
MW
: 342.69
Sodium Valproate
Therapy
: Central nervous system and pain
Target
:
CAS
: 1069-66-5
MF
: C8H15NaO2
MW
: 166.19
Sumatriptan Succinate
Therapy
: Central nervous system and pain
Target
:
CAS
: 103628-48-4
MF
: C18H27N3O6S
MW
: 413.48848
Tizanidine Hydrochloride
Therapy
: Central nervous system and pain
Target
:
CAS
: 64461-82-1
MF
: C9H9Cl2N5S
MW
: 290.17
Topiramate
Therapy
: Central nervous system and pain
Target
: CA4;AMPAR;CAs;Kainic acid receptor;CA2;GABAT;Sodium channels;GABAAR
CAS
: 97240-79-4
MF
: C12H21NO8S
MW
: 339.36
Valproic Acid
Therapy
: Central nervous system and pain
Target
:
CAS
: 99-66-1
MF
: C8H16O2
MW
: 144.21